Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis

Abstract Objective Neonatal sepsis, a severe infectious disease associated with high mortality rates, is characterized by metabolic disturbances that play a crucial role in its progression. The aim of this study is to develop a metabolism-related model for assessing 30-day mortality in neonatal seps...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiangwen Tu, Junkun Chen, Wen Liu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-025-10527-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571953238507520
author Xiangwen Tu
Junkun Chen
Wen Liu
author_facet Xiangwen Tu
Junkun Chen
Wen Liu
author_sort Xiangwen Tu
collection DOAJ
description Abstract Objective Neonatal sepsis, a severe infectious disease associated with high mortality rates, is characterized by metabolic disturbances that play a crucial role in its progression. The aim of this study is to develop a metabolism-related model for assessing 30-day mortality in neonatal sepsis. Methods The clinical data of neonatal sepsis at Ganzhou Women and Children’s Health Care Hospital from January 2019 to December 2022 were retrospectively analyzed. Neonatal sepsis cases were divided into survival and non-survival groups. Multivariate logistic regression analysis was used to identify the independent risk factors for 30-day mortality. A nomogram model was developed based on these risk factors. Internal validation of the model was performed using 10-fold cross-validation. The predictive performance was evaluated through receiver operating characteristic (ROC) curves and calibration curve analyses. Decision curve analysis (DCA) was conducted to evaluate the clinical applicability of the developed model. Results The study included a total of 156 cases of neonatal sepsis. Multivariate logistic regression analysis revealed that alanine(ALA), citrulline(CIT)), octadecanoylcarnitine(C18) and methionine(MET) were identified as independent risk factors for 30-day mortality of neonatal sepsis. The ROC curve showed an area under the curve of AUC = 0.866 (95% CI 0.796–0.936, P < 0.05). The calibration curve and DCA indicated excellent performance of the model. Conclusion This study establishes a predictive model for neonatal sepsis-associated 30-day mortality, effectively capturing the perturbations in amino acid metabolism and fatty acid oxidation, thereby demonstrating robust predictive capabilities.
format Article
id doaj-art-bfb53210e6d647ceb39dfe13ebc8b904
institution Kabale University
issn 1471-2334
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-bfb53210e6d647ceb39dfe13ebc8b9042025-02-02T12:10:43ZengBMCBMC Infectious Diseases1471-23342025-01-012511910.1186/s12879-025-10527-zDevelopment and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsisXiangwen Tu0Junkun Chen1Wen Liu2Laboratory of Eugenics Genetics, GanZhou Women and Children’s Health Care HospitalLaboratory of Eugenics Genetics, GanZhou Women and Children’s Health Care HospitalNeonatal intensive care Unit, GanZhou Women and Children’s Health Care HospitalAbstract Objective Neonatal sepsis, a severe infectious disease associated with high mortality rates, is characterized by metabolic disturbances that play a crucial role in its progression. The aim of this study is to develop a metabolism-related model for assessing 30-day mortality in neonatal sepsis. Methods The clinical data of neonatal sepsis at Ganzhou Women and Children’s Health Care Hospital from January 2019 to December 2022 were retrospectively analyzed. Neonatal sepsis cases were divided into survival and non-survival groups. Multivariate logistic regression analysis was used to identify the independent risk factors for 30-day mortality. A nomogram model was developed based on these risk factors. Internal validation of the model was performed using 10-fold cross-validation. The predictive performance was evaluated through receiver operating characteristic (ROC) curves and calibration curve analyses. Decision curve analysis (DCA) was conducted to evaluate the clinical applicability of the developed model. Results The study included a total of 156 cases of neonatal sepsis. Multivariate logistic regression analysis revealed that alanine(ALA), citrulline(CIT)), octadecanoylcarnitine(C18) and methionine(MET) were identified as independent risk factors for 30-day mortality of neonatal sepsis. The ROC curve showed an area under the curve of AUC = 0.866 (95% CI 0.796–0.936, P < 0.05). The calibration curve and DCA indicated excellent performance of the model. Conclusion This study establishes a predictive model for neonatal sepsis-associated 30-day mortality, effectively capturing the perturbations in amino acid metabolism and fatty acid oxidation, thereby demonstrating robust predictive capabilities.https://doi.org/10.1186/s12879-025-10527-zAmino acidsAcylcarnitinesMortalityNeonatal sepsisPrognosis
spellingShingle Xiangwen Tu
Junkun Chen
Wen Liu
Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis
BMC Infectious Diseases
Amino acids
Acylcarnitines
Mortality
Neonatal sepsis
Prognosis
title Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis
title_full Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis
title_fullStr Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis
title_full_unstemmed Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis
title_short Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis
title_sort development and internal validation of a metabolism related model for predicting 30 day mortality in neonatal sepsis
topic Amino acids
Acylcarnitines
Mortality
Neonatal sepsis
Prognosis
url https://doi.org/10.1186/s12879-025-10527-z
work_keys_str_mv AT xiangwentu developmentandinternalvalidationofametabolismrelatedmodelforpredicting30daymortalityinneonatalsepsis
AT junkunchen developmentandinternalvalidationofametabolismrelatedmodelforpredicting30daymortalityinneonatalsepsis
AT wenliu developmentandinternalvalidationofametabolismrelatedmodelforpredicting30daymortalityinneonatalsepsis